HSD51 Premature Treatment Discontinuation Among Previously Untreated Medicare Beneficiaries With Chronic Lymphocytic Leukemia Treated With Oral Targeted Therapies: A Real-World Analysis
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.947
https://www.valueinhealthjournal.com/article/S1098-3015(25)01072-1/fulltext
Title :
HSD51 Premature Treatment Discontinuation Among Previously Untreated Medicare Beneficiaries With Chronic Lymphocytic Leukemia Treated With Oral Targeted Therapies: A Real-World Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)01072-1&doi=10.1016/j.jval.2025.04.947
First page :
Section Title :
Open access? :
No
Section Order :
10654